<DOC>
	<DOCNO>NCT00203255</DOCNO>
	<brief_summary>The purpose trial study use soy isoflavones prevention menstrually-associated migraine . Additionally , trial may provide insight menstrual cycle menstrually-related headache woman . With information , may able change current treatment method even develop new method order advance current approach treatment menstrual migraine .</brief_summary>
	<brief_title>Clinical Study Examining Use Over-the-Counter Supplement Prevention Menstrually-Associated Migraine Headache</brief_title>
	<detailed_description>Many woman increase headache attack time period ( menses ) . The migraine experience around menstrual cycle often associate premenstrual complaint nausea , backache breast tenderness . The condition hormone-related headache ( i.e . menstrual migraine ) unclear . Soy isoflavones use alleviate symptom menopause . They contain natural estrogen ( female hormone ) . Since menstrual migraine think associate withdrawal estrogen , natural fall estrogen level , use natural source estrogen may helpful prevention menstrually-associated migraine .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>•Subjects experience regular menstrual cycle past 6 month ( every 21 35 day ) •Subjects history migraine without aura meet IHS criterion least 6 month precede study . •Subjects headache associate menstruation , either premenstrually menstrually ( define day 3 cessation menstrual flow ) least 75 % time ( 3 past 4 month ) . •Subjects must experience menstruallyassociated migraine baseline month , define . •Subjects must able accurately predict onset menses ( within 2 day ) . This confirmed baseline month . •Subjects stable headache preventive medication 3 month prior screen . •Subject negative urine pregnancy test prior study entry , use agrees use duration participation medically acceptable form contraception ( determined investigator ) , female childbearing potential •Subject able understand comply study requirement •Subject provide write informed consent prior screen procedure conduct Subjects breastfeeding , pregnant planning become pregnant within next 4 month . •Subjects currently within three month prior screen ; hormonal contraceptive ( oral , injection , implant ) , hormone replacement therapy hormone therapy include natural supplement . •Subjects , investigator opinion , history evidence medical psychiatric condition would expose increase risk significant adverse event would interfere assessment efficacy tolerability trial •Subjects experience great 15 headache day per month •Subjects allergy soy soy base product . •Subjects history significant drug alcohol abuse within past year Subjects participate investigational drug trial 30 day prior screen visit •Subjects breast cancer history breast cancer .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Menstrually-Associated Migraine</keyword>
</DOC>